SPEARHEAD DEVELOPMENT GROUP LIMITED

Executive Summary

Spearhead Development Group Limited displays solid financial health with positive net assets and working capital, indicating ongoing solvency and operational viability. However, a significant reduction in cash and current assets in the latest year warrants careful cash flow monitoring and management. Strategic investments suggest growth ambitions, but ensuring liquidity remains robust will be critical for sustaining future financial wellness.

SPEARHEAD DEVELOPMENT GROUP LIMITED - Analysis Report

Company Number: 12753241

Analysis Date: 2025-07-19 12:05 UTC

Financial Health Assessment of SPEARHEAD DEVELOPMENT GROUP LIMITED

---

1. Financial Health Score: B

Explanation:
Spearhead Development Group Limited demonstrates generally sound financial health with positive net assets and working capital throughout recent years. However, there are signs of mild stress in liquidity and asset turnover in the latest year, especially a significant drop in current assets and cash balances compared to prior years. This suggests a need for close monitoring and potential corrective actions to sustain financial wellness.

---

2. Key Vital Signs

Metric	2024 Value (£)	Interpretation
Fixed Assets	56,600	Moderate investment in long-term assets; increased due to new subsidiary investment. Healthy for business infrastructure.
Current Assets	55,174	Sharp decline from £147,583 in 2023, signaling lower liquid resources and receivables — potential liquidity concern.
Cash & Cash Equivalents	26,796	Reduced substantially from £58,999 in prior year; indicates reduced cash buffer or increased cash outflows.
Debtors	23,543	Decreased from £83,067; could imply faster collection or reduced sales on credit, which affects cash inflows.
Current Liabilities	21,794	Reduced from £56,924; positive as short-term obligations decreased, easing immediate financial pressure.
Net Current Assets (Working Capital)	33,380	Positive but reduced from £90,659; indicates liquidity is still sufficient but less robust than before.
Net Assets (Equity)	86,898	Healthy positive net assets, though reduced from £106,991, still shows solid shareholder equity.
Profit & Loss Reserves	86,878	Accumulated retained earnings remain positive, indicating a history of profitability or retained funds.

---

3. Diagnosis: Financial Health Analysis

Vital Signs Evaluation:

• The company maintains a positive net asset base and working capital, which are the "heartbeat" of financial health. This suggests the company is solvent and able to meet its obligations.
• The significant reduction in current assets and cash "reserves" in 2024 compared to 2023 is a "symptom" of potential cash flow tightening or reduced sales activity. This could indicate either a strategic investment phase or operational slowdown.
• The investment in fixed assets, particularly a £39,835 investment in a subsidiary, reflects a growth-oriented activity, which is a positive sign but also ties up cash resources.
• Decrease in trade debtors could reflect improved cash collections or reduced credit sales; if due to reduced sales, this could be a mild "symptom of distress" in revenue generation.
• The reduction in current liabilities is a positive sign, easing short-term financial pressure and improving liquidity ratios.
• Provisions for deferred tax liabilities have decreased, indicating a slight improvement in tax-related future obligations.

Underlying Business Health:

• The company operates in electrical installation (SIC 43210), a sector that can be capital and cash intensive with variable payment terms.
• The director is the sole significant controller, which may streamline decision-making but also concentrates financial risk.
• The company has been exempt from audit, which is typical for a small company but means external verification of financial health is limited.
• Overall, the company exhibits signs of a "healthy but cautious" financial condition with manageable liquidity and solvency but with a need to monitor cash flow closely.

---

4. Recommendations: Path to Improved Financial Wellness

1. Enhance Cash Flow Management:

   • Investigate causes for the sharp reduction in cash and current assets. If due to slower receivables collection, tighten credit control and improve debtor days.
   • Maintain a cash buffer to avoid liquidity stress, especially given the capital investments.

2. Monitor Debtor and Creditor Cycles:

   • Ensure debtor aging is healthy and that payments from clients are timely.
   • Negotiate payment terms with suppliers to optimise working capital without jeopardizing relationships.

3. Review Capital Investments:

   • Assess the subsidiary investment's return prospects and timing. Ensure it aligns with the company’s strategic goals and does not overstrain cash flows.

4. Budget for Tax and Provisions:

   • Maintain or improve provisions for liabilities and tax to avoid unexpected cash outflows.

5. Consider Diversifying Revenue Streams:

   • If the decline in debtors reflects reduced sales, explore new contracts or markets to increase turnover and improve cash inflows.

6. Maintain Strong Governance and Compliance:

   • Ensure timely filing and compliance to avoid penalties or reputational risk.

---

Medical Analogy Summary:

The company’s financial “vital signs” show a stable “heartbeat” with positive net assets and working capital, but the recent drop in “blood volume” (cash and current assets) signals a need for close “monitoring of circulation” (cash flow). The “growth injection” (subsidiary investment) is promising but requires careful management to avoid “overload.” With attentive management, the company can maintain its “health” and thrive.

---